News Pharmaspectra appoints UDG’s Jez Moulding as CEO Jez Moulding has moved from UDG and its Ashfield business to join and lead medical science information company Pharmaspectra.
News Merck rare tumour drug Ezmekly backed for NHS use Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
